Study Evaluating the Analgesic Efficacy and Safety of ADL5859 in Subjects With Rheumatoid Arthritis - Related Studies

Study Evaluating the Analgesic Efficacy and Safety of ADL5859 in Subjects With Rheumatoid Arthritis (33CL232)

This study has been completed.

Study NCT00626275. Last updated on October 27, 2008. Information provided by Adolor Corporation

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Rheumatoid Arthritis

2	Additional conditions recognized in this trial
		Arthritis
		Arthritis, Rheumatoid

3	More general conditions related to this trial
		Autoimmune Diseases
		Connective Tissue Diseases
		Immune System Diseases
		Joint Diseases
		Musculoskeletal Diseases
		Rheumatic Diseases

4	Interventions listed in this trial
		ADL5859
		naproxen
		Placebo
		Lactose monohydrate, NF

5	More general drug interventions related to this trial
		Analgesics
		Analgesics, Non-Narcotic
		Anti-Inflammatory Agents
		Anti-Inflammatory Agents, Non-Steroidal
		Antirheumatic Agents
		Central Nervous System Agents
		Cyclooxygenase Inhibitors
		Enzyme Inhibitors
		Gout Suppressants
		Molecular Mechanisms of Pharmacological Action
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Sensory System Agents
		Therapeutic Uses

6	Sponsors listed in this trial
		Adolor Corporation